当前位置:首页 - 行情中心 - 科莱瑞迪(920072) - 财务分析 - 利润表

科莱瑞迪

(920072)

  

流通市值:3.46亿  总市值:18.35亿
流通股本:1446.50万   总股本:7660.00万

利润表

报告期2026-06-302026-03-312025-12-312025-06-30
公司类型通用通用通用通用
一、营业总收入176,638,318.6277,262,592.08315,268,096.64152,167,602.53
  营业收入176,638,318.6277,262,592.08315,268,096.64152,167,602.53
二、营业总成本136,071,914.6461,209,059.1239,701,498.95114,124,679.65
  营业成本69,956,49029,451,009.41125,097,932.7459,272,310.18
  税金及附加2,646,311.61,279,651.544,522,197.22,101,757.75
  销售费用32,551,786.0815,322,787.1360,129,856.3428,644,941.07
  管理费用16,230,158.138,207,037.1626,732,737.0813,496,082.16
  研发费用12,588,400.025,956,890.4123,225,181.4211,221,811.95
  财务费用2,098,768.81991,683.45-6,405.83-612,223.46
  其中:利息费用63,595.4133,215.421,448,766.811,341,711.18
  其中:利息收入1,172,679.99547,120.123,176,892.31,861,261.09
三、其他经营收益
  加:公允价值变动收益26,113.89--2,954.5811,843.31
  加:投资收益824,618.53187,550.52-3,774,329.5-2,527,604.47
  净敞口套期收益0--0
  汇兑收益0--0
  资产处置收益-10,026.311,418-293,271.19-61,030.13
  资产减值损失(新)-861,116.49-337,972.08-968,934.24-872,458.35
  信用减值损失(新)-702,667.89604,234.04-123,637.21292,692.61
  其他收益707,187.29613,995.554,152,347.1871,535.93
四、营业利润40,550,51317,122,759.0174,555,818.0735,757,901.78
  加:营业外收入24,448.7815,019.529,025.9923,280.15
  减:营业外支出344,505.42118,978.69378,258.34241,677.08
五、利润总额40,230,456.3617,018,799.8274,206,585.7235,539,504.85
  减:所得税费用5,013,154.752,315,217.2510,168,145.044,996,741.42
六、净利润35,217,301.6114,703,582.5764,038,440.6830,542,763.43
(一)按经营持续性分类
  持续经营净利润35,217,301.6114,703,582.5764,038,440.6830,542,763.43
(二)按所有权归属分类
  归属于母公司股东的净利润35,217,301.6114,703,582.5764,038,440.6830,542,763.43
  扣除非经常损益后的净利润34,590,126.5414,311,921.960,996,087.5229,895,832.61
七、每股收益
  (一)基本每股收益0.570.241.040.49
  (二)稀释每股收益0.570.241.040.49
八、其他综合收益-138,333.48-69,244.81-97,453.93-18,042.02
  归属于母公司股东的其他综合收益-138,333.48-69,244.81-97,453.93-18,042.02
九、综合收益总额35,078,968.1314,634,337.7663,940,986.7530,524,721.41
  归属于母公司股东的综合收益总额35,078,968.1314,634,337.7663,940,986.7530,524,721.41
公告日期2026-08-262026-05-112026-01-232025-08-26
审计意见(境内)标准无保留意见标准无保留意见
TOP↑